K, Y., R, K., R, S., JD, B., K, O., BA, H., & PB, W. (2024). Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients. Clinical pharmacology and therapeutics, 115(3), 525. https://doi.org/10.1002/cpt.3136
Chicago Style (17th ed.) CitationK, Yang, Kong R, Spiegel R, Baird JD, O'Keefe K, Howell BA, and Watkins PB. "Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients." Clinical Pharmacology and Therapeutics 115, no. 3 (2024): 525. https://doi.org/10.1002/cpt.3136.
MLA (9th ed.) CitationK, Yang, et al. "Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients." Clinical Pharmacology and Therapeutics, vol. 115, no. 3, 2024, p. 525, https://doi.org/10.1002/cpt.3136.